Unusual But Yet Realistic Oxygenase Tactics

Results A total of 707 patients (age 69.4 �� 14.1 years) with an EF �� 35% met inclusion criteria. Echocardiogram was the most common method utilized for EF measurement (84% patients) followed by thallium stress test, ventriculogram and multigated nuclear scan (MUGA). Mean EF was 26��7%. NYHA (New York Heart Association) class 1, 2, 3 and 4 were seen in 30%, 40%, 26% and 4% of patients respectively. Mean QRS duration was 125��36 ms. The majority of patients were males (66%) and of Caucasian race (80%). Ischemic cardiomyopathy was seen in 59% of Oxygenase patients while 41% had non-ischemic cardiomyopathy. Mean duration of cardiomyopathy (LV dysfunction) was 76��21 months. Percentages of patients on ASA, BB and ACE/ARB were 80%, 81% and 75% respectively at 1 year of heart failure diagnosis. AA, digoxin and statins were used in 24%, 50% and 68% of patients respectively. Eighty percent were on diuretics. ICDs were implanted BKM120 in only 28% of patients (n = 200/707). There was a significant difference in all cause mortality between HF patients with ICDs compared to those without (25% vs 37%, p=0.004). Figure 1 shows Kaplan-Meier survival curves for patients with and without ICD. Age (HR 1.02, CI 1.01-1.03 pNU7441 mw therapy for primary prevention for patients with ischemic and non ischemic cardiomyopathy with EF ischemic cardiomyopathy with EF